Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Pejčić Ivica"'
Publikováno v:
Vojnosanitetski Pregled, Vol 73, Iss 11, Pp 1072-1075 (2016)
Introduction. Synchronous occurrence of lymphomas and other cancers, mostly carcinomas are well established. The most of cases describe chronic lymphocytic leukemia as the leading lymphoproliferative disease with the tendency towards secondary malign
Externí odkaz:
https://doaj.org/article/3876f71f0f7c488488dc9cbe4f26c380
Autor:
Kandolf-Sekulović Lidija, Babović Nada, Balić Mirjana, Nikolin Borislava, Nikolić Dejan, Janjić Zlata, Jokić Neven, Mijušković Željko, Rajović Milica, Novaković Marijan, Vrbić Svetislav, Pejčić Ivica, Kovačević Predrag, Mihajlović Dragan, Roganović Tatjana, Ferenc Vicko, Nikolić Jelena, Marinković Marija, Bizetić Zorana
Publikováno v:
Vojnosanitetski Pregled, Vol 72, Iss 4, Pp 312-316 (2015)
Background/Aim. Treatment options for metastatic melanoma in Serbia are limited due to the lack of newly approved biologic agents and the lack of clinical studies. Also, there is a paucity of data regarding the treatment approaches in different te
Externí odkaz:
https://doaj.org/article/6665f3c7fbef42b28fe90ca92b8201d0
Autor:
Pejčić Ivica, Vrbić Svetislav, Filipović Slađana, Šćekić Mirjana, Petković Ivan, Pejčić Ljiljana, Đenić Nebojša
Publikováno v:
Vojnosanitetski Pregled, Vol 67, Iss 9, Pp 723-731 (2010)
Background/Aim. Unknown primary tumors represent a heterogeneous group of malignancies that are indicative of ominous prognosis. Cancer of unknown primary site (CUP) is defined as the lack of any detectable primary site after full evaluation, and acc
Externí odkaz:
https://doaj.org/article/35678782203448e380a61a082f4b878b
Autor:
Filipović Slađana, Filipović Aleksandra, Stojiljković Vladimir, Mišić Ivana, Vrbić Svetislav, Pejčić Ivica, Stanojević Zorica
Publikováno v:
Journal of Medical Biochemistry, Vol 26, Iss 2, Pp 134-143 (2007)
Breast cancer (BC) is a disease underlined by a complex aetiology, natural history and disease behaviour. Age is the greatest risk factor, which coupled with genetic predisposition, hormonal phenotype, reproductive profile and extrinsic factors, make
Externí odkaz:
https://doaj.org/article/4c81f51202db4226a4741e7d482b21be
Autor:
Pejčić Ivica, Vrbić Svetislav, Filipović Slađana, Pejčić Ljiljana, Jovanović Bratislav, Šćekić Mirjana, Filipović Aleksandra
Publikováno v:
Archive of Oncology, Vol 12, Iss 1, Pp 25-28 (2004)
BACKGROUND: Metastatic melanoma has shown only limited responsiveness to chemotherapy or immunotherapy. The most commonly used single-agent chemotherapy comes from the nitrosourea group of agents and provides response rates of less than 20%. Several
Externí odkaz:
https://doaj.org/article/04998875f0364e4182c43762054d6783
Autor:
Pejčić Ivica, Vrbić Svetislav
Publikováno v:
Archive of Oncology, Vol 17, Iss 3-4, Pp 65-67 (2009)
Out of numerous studied monoclonal antibodies, only a few reached the stage of clinical application. The CD20 molecule, non-glycolysed phospholipoprotein (usually termed B1), belonging to the tetraspan (TM4SF) family, 35-37 kD, is characteristic for
Externí odkaz:
https://doaj.org/article/eef71b2409a84257b992c2c5b9f07ec5
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 149-149 (2003)
Chemotherapy of breast cancer is still the area of intensive research. Based on mathematical model of tumor cell growth kinetics, articulated by Larry Norton, novel concept of chemotherapy in breast cancer was launched and it implies dose-densificati
Externí odkaz:
https://doaj.org/article/186d15ac06b44bcc97aef49c19f2fe77
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 187-187 (2003)
Background: Anaplastic thyroid carcinoma (ATC) is a very rare and extremely aggressive cancer; patient's death usually occurs rapidly after diagnosis with a mean survival of six months in the majority of individual research series. Treatment of ATC r
Externí odkaz:
https://doaj.org/article/0b6ca68faa1349d4ad8be91613835fa7
Autor:
Petković, Ivan Z.1 ivan76.unsu@yahoo.com, Pejčić, Ivica1, Tiodorović, Danica2, Krstić, Miljan3, Stojnev, Slavica3, Vrbić, Svetislav1
Publikováno v:
Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii. Dec2017, Vol. 34 Issue 6, p625-628. 4p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.